The Top Line
The Top Line
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech and Fierce Pharma recount the latest industry trends and why they matter. We’ll analyze the week’s biggest business news—from mergers and marketing to drug R&D and device development. Available every Friday morning.Social links:
February 3rd, 2023
After a complicated 2022, the new year offers a course correction for the obesity market. We'll hear from Fierce's Fraiser Kansteiner and Querida Anderson on the numerous opportunities ahead in the obesity market. Also on the show, Fierce's Kevin Dunleavy and Eric Sagonowsky reflect on the the 37…
31:39
January 27th, 2023
Just last year, congress passed the Inflation Reduction Act. The law contains several drug pricing measures hated by the pharmaceutical industry, including restrictions to price increases and Medicare negotiations. Eric Sagnowsky talked with Stacie Dusetzina, a professor at Vanderbilt University's …
31:53
January 20th, 2023
Fierce’s JPM Week event was packed full of informative panels, executive interviews and fireside chats. So for today’s episode, we’ve pulled out a couple of snippets to take you inside the gathering. First up, listen in on Fraiser Kansteiner’s lively panel discussion on how companies will keep the…
33:09
January 13th, 2022
The FDA is making some changes in the accelerated approval process. In this episode, we’ll discuss the recent changes with the FDA’s regulation of cancer drugs and how these shifts will impact the biopharma industry. Also in this episode, we cover the week's biggest headlines from the annual J.P…
26:08
January 6th, 2022
There were a lot of moments in 2022 that left us scratching our heads. In this episode, we’ll recap biotech’s top blunders, boondoggles, gaffes and missteps in our "Rotten Tomatoes" report—plus, we highlight two ripened tomatoes that gave us hope. Also in this episode, we cover the week's bigges…
19:17
December 16th, 2022
We totaled the salaries, stock options and bonuses awarded to various medtech CEOs to figure out who the highest paid chiefs were. And our top 10 list saw a few ups and downs over the past year. We'll hear from Connor Hale and Andrea Park as they discuss medtech's highest paid CEOs. Also in this e…
14:46
December 9th, 2022
Last week, senior editor Annalee Armstrong and staff writer Gabrielle Mason covered the Clinical Trials on Alzheimer’s Disease conference. We'll hear from them as they discuss the latest news and what surprised them. Also in this episode, we cover the week's biggest headlines including an invest…
17:12
December 2nd, 2022
Biogen recently named Christopher Viehbacher its new CEO, ending a monthslong search to replace Michel Vounatsos. Fraiser Kansteiner and Kevin Dunleavy talk about the current state of the company and recent investor reactions to the new hire. Plus, they discuss a string of other biopharma CEO appoi…
15:57
[Sponsored] Slope’s Hope Meely on the importance of a fully enabled clinical supply platform
Learn how Slope’s eClinical Supply Chain Management platform provides robust technology to the clinical trial space, covering all areas of supply management without losing sight of the chain of custody.
20:50Clean
November 18th, 2022
This week on "The Top Line," we discuss 2022’s Fiercest Women in Life Science honorees. Each year, we spotlight women who are leading the way in life sciences—women who stand out as leaders, innovators and mentors. We’ll hear from Andrea Park and Querida Anderson on what it took to make the cut for…
25:03